Cargando…

Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes

The post-acute sequelae of SARS-CoV-2 infection (PASC) refers to a broad spectrum of symptoms and signs that are persistent, exacerbated or newly incident in the period after acute SARS-CoV-2 infection. Most studies have examined these conditions individually without providing evidence on co-occurri...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hao, Zang, Chengxi, Xu, Zhenxing, Zhang, Yongkang, Xu, Jie, Bian, Jiang, Morozyuk, Dmitry, Khullar, Dhruv, Zhang, Yiye, Nordvig, Anna S., Schenck, Edward J., Shenkman, Elizabeth A., Rothman, Russell L., Block, Jason P., Lyman, Kristin, Weiner, Mark G., Carton, Thomas W., Wang, Fei, Kaushal, Rainu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873564/
https://www.ncbi.nlm.nih.gov/pubmed/36456834
http://dx.doi.org/10.1038/s41591-022-02116-3
Descripción
Sumario:The post-acute sequelae of SARS-CoV-2 infection (PASC) refers to a broad spectrum of symptoms and signs that are persistent, exacerbated or newly incident in the period after acute SARS-CoV-2 infection. Most studies have examined these conditions individually without providing evidence on co-occurring conditions. In this study, we leveraged the electronic health record data of two large cohorts, INSIGHT and OneFlorida+, from the national Patient-Centered Clinical Research Network. We created a development cohort from INSIGHT and a validation cohort from OneFlorida+ including 20,881 and 13,724 patients, respectively, who were SARS-CoV-2 infected, and we investigated their newly incident diagnoses 30–180 days after a documented SARS-CoV-2 infection. Through machine learning analysis of over 137 symptoms and conditions, we identified four reproducible PASC subphenotypes, dominated by cardiac and renal (including 33.75% and 25.43% of the patients in the development and validation cohorts); respiratory, sleep and anxiety (32.75% and 38.48%); musculoskeletal and nervous system (23.37% and 23.35%); and digestive and respiratory system (10.14% and 12.74%) sequelae. These subphenotypes were associated with distinct patient demographics, underlying conditions before SARS-CoV-2 infection and acute infection phase severity. Our study provides insights into the heterogeneity of PASC and may inform stratified decision-making in the management of PASC conditions.